Clinical Trial

Hyperventilation in Patients With Chronic Low Back Pain

Study acronym: HELBP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Low back pain (LBP) is the leading cause of disability worldwide. Impaired postural control is a key factor in the development and maintenance of LBP. Moreover, the prevalence of LBP is associated with impairments in diaphragm function, symptoms of dyspnea, and dysfunctional breathing. However, the association between LBP (and more specifically postural control) and hyperventilation remains unknown. The main objective of this project is to investigate whether the presence of recurrent non-specific LBP is related to the presence of hyperventilation, when classified either objectively by decreased carbon dioxide values (demonstrating hypocapnia) or by symptoms while showing normal carbon dioxide values. Moreover, the investigators will explore whether psychosocial factors play a role in this relation. Subsequently, the investigators will examine whether hyperventilation in LBP patients is related to impaired postural control, and more specifically to a decreased postural contribution of the diaphragm.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-08-28; most recent amendment 2024-08-21.
Status change: Not Yet Recruiting → Recruiting 2020-08-03
Trial Details
NCT Number NCT04074798
Lead Sponsor Hasselt University
Collaborators: ZOL
Conditions Low Back Pain, Recurrent, Hyperventilation Syndrome
Enrollment 90 participants
Start Date 2020-03-01
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-08-22